Investments in next-generation manufacturing facilities are unlocking scale, speed, and quality for cell and gene therapies, propelling North …
Investments in next-generation manufacturing facilities are unlocking scale, speed, and quality for cell and gene therapies, propelling North …
European regulatory reforms are accelerating approvals for novel rare disease treatments, attracting global investment and expanding patient access.
Asia-Pacific biopharma conferences in early 2025 are forging strategic partnerships, launching research initiatives, and accelerating drug development.
Record venture investment is driving new biotech companies in Australia to accelerate research, clinical development, and global partnerships.
Landmark clinical results suggest preventative therapy could delay or halt Alzheimer’s onset in high-risk individuals, reshaping the outlook …
An established diagnostics firm gains critical funding to advance its wearable glucose monitoring technology and drive a strategic …
Large funding rounds and strategic partnerships highlight a more focused investment environment, concentrating on companies with late stage …
Two key players in immunology and vaccine innovation gain financial momentum as they push forward with mRNA vaccines …
A wave of major financings and collaborations on February 25 signals renewed investor confidence in biotech, with giants …
A landmark multi-hundred million dollar collaboration between Takeda and BridGene Biosciences redefines biotech funding trends this week, joined …
